Streetbeat News

Price Targets

EW

Evercore ISI Group analyst Vijay Kumar has downgraded Edwards Lifesciences (NYSE:EW) from Outperform to In-Line and reduced the price target from $80 to $77.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 5:11 pm

BLCO

Evercore ISI Group analyst Vijay Kumar downgraded Bausch & Lomb (NYSE:BLCO) from Outperform to In-Line and reduced the price target from $19 to $17.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 5:08 pm

ZBH

Evercore ISI Group analyst Vijay Kumar downgraded Zimmer Biomet Holdings (NYSE:ZBH) from Outperform to In-Line and reduced the price target from $135 to $125.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 5:06 pm

SNOW

Monness, Crespi, Hardt analyst Brian White downgraded Snowflake (NYSE:SNOW) from Neutral to Sell and set a price target of $160.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 5:02 pm

RIVN

Rivian Automotive (NASDAQ:RIVN) has received mixed evaluations from 8 analysts in the past three months, with an average 12-month price target of $24.62, down from the previous $27.50. Recent actions include lowered price targets by Goldman Sachs, Cantor Fitzgerald, Wells Fargo, and Wedbush, while Stifel, Cantor Fitzgerald, Needham, and UBS have given positive ratings. Rivian's financials show strong revenue growth but a high net margin loss, below-average ROE and ROA, and a conservative debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 04, 2024 | 5:00 pm

AVTR

Avantor (NYSE:AVTR) has been evaluated by 8 analysts over the last three months, with a mix of bullish and somewhat bullish ratings. The average 12-month price target is $23.94, up from the previous $22.50. Analysts from firms like Evercore ISI Group, Deutsche Bank, Barclays, TD Cowen, Goldman Sachs, Morgan Stanley, and Raymond James have updated their ratings and price targets, reflecting changes in market conditions and company performance. Avantor operates in various industries and has a lower market capitalization compared to industry averages. Its revenue growth has declined by -7.34%, but it maintains a high net margin of 6.3% and an exceptional ROE of 2.14%. However, its debt-to-equity ratio of 1.1 is higher than the industry average.

Portfolio Pulse from Benzinga Insights

January 04, 2024 | 5:00 pm

MLAB

Evercore ISI Group has upgraded Mesa Laboratories (NASDAQ:MLAB) from an unspecified rating to Outperform, raising the price target from $100.00 to $125.00. This represents a potential increase of 28.56% from the current share price of $97.23. Mesa Laboratories operates in life sciences tools and critical quality control products across four divisions. Analyst ratings are provided by financial analysts and are used by investors to help guide stock decisions.

Portfolio Pulse from Benzinga Insights

January 04, 2024 | 5:00 pm

ACLX

Needham has reaffirmed its Buy rating on Arcellx (NASDAQ:ACLX) and increased its price target from $65.00 to $71.00, implying a potential upside of 29.78% from the current share price of $54.71. Arcellx is a clinical-stage biotech company focused on developing cell therapies for cancer and other diseases.

Portfolio Pulse from Benzinga Insights

January 04, 2024 | 5:00 pm

PKG

Packaging Corp of America (NYSE:PKG) received diverse analyst ratings over the last three months, with a recent shift towards a more bullish outlook. The average 12-month price target for PKG has increased to $161.6, up 6.74% from the previous target. Analysts from Truist Securities, Wells Fargo, Citigroup, and Jefferies have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. PKG's financials show a negative revenue trend with a -8.93% decline, but strong profitability with a high net margin of 9.39% and above-average ROE and ROA. The company's debt-to-equity ratio is conservative at 0.71.

Portfolio Pulse from Benzinga Insights

January 04, 2024 | 5:00 pm

GES

Jefferies has downgraded Guess (NYSE:GES) from a previous rating to Hold, adjusting the price target from $25.00 to $24.00. Guess shares have fallen 4.35% in the last 24 hours to $22.23. The new price target suggests a potential upside of 7.96% from the current price. Guess operates in various segments, with Europe being the most revenue-generating. Analyst ratings, such as this one from Jefferies, are periodic evaluations of stocks that can influence investor decisions.

Portfolio Pulse from Benzinga Insights

January 04, 2024 | 5:00 pm